| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |